News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Health Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging deal
Health & Biotech
Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair
Health & Biotech
ASX Health Stocks: Clinuvel, MedAdvisor rally after hitting high notes on profits
Health & Biotech
ASX Health Stocks: Amplia’s pancreatic cancer drug shows progress
News
ASX Small Caps Lunch Wrap: Has Japan unleashed a new colossal death robot this week?
Health & Biotech
ASX Health Stocks: Cardiex jumps 15pc on sales update; Recce’s drug included in WHO’s report
Health & Biotech
ASX Health Stocks: Polynovo to get first orders in India; Clinuvel reports good results from Phase 2
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘up and down’ reporting season
News
Short & Caught: Pilbara Minerals ASX’s most shorted as lithium stocks targeted
News
Brokers on Monday: Clinuvel finds friends; ANZ’s unimpressive outlook
Health & Biotech
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
Health & Biotech
ScoPo’s Powerplays: Should have stayed in bed as ASX stocks fall but Neuren makes S&P ASX 200
News
Closing Bell: Hawkish RBA helps extend ASX losses; Indiana Resources surges as Ansell tanks
News
ASX Small Caps Lunch Wrap: Who got stuck into the magic mushies in China last week?
Health & Biotech
